News & Resources
December 19, 2020

Like It? Share It

Moderna COVID-19 Vaccine Review and Analysis

Resources

The Food and Drug Administration granted an Emergency Use Authorization for the Moderna COVID-19 vaccine.

The TeamHealth Emerging Infectious Disease Task Force (EIDT) analyzed Moderna vaccine trial data and reached the following, unanimous conclusion:

The EIDT strongly recommends vaccination with the Moderna COVID-19 vaccine for all adults 18 years of age and above and every racial and ethnic demographic regardless of COVID-19 risk factors, prior COVID-19 infection, or other underlying health conditions, unless there are clear, existing contraindications to receiving any vaccine.

The EIDT is committed to synthesizing and offering you the most up-to-date information related to COVID-19. Download the full EIDT Moderna COVID-19 vaccine analysis below.

 

Download